Insulin Resistance and Adiposity in Relation to Serum β-Carotene Levels

Division of Pediatric Endocrinology and Metabolism, Nemours Children's Clinic, Jacksonville, FL 32207, USA.
The Journal of pediatrics (Impact Factor: 3.79). 02/2012; 161(1):58-64.e1-2. DOI: 10.1016/j.jpeds.2012.01.030
Source: PubMed


To determine the effects of placebo vs an encapsulated supplement of fruit and vegetable juice concentrate (FVJC) on serum β-carotene levels, insulin resistance, adiposity, and subclinical inflammation in boys.
Thirty age-matched prepubertal boys (9 lean and 21 overweight (OW); age range, 6-10 years) were studied. All participants received nutrition counseling and were randomized to receive FVJC or placebo capsules for 6 months. Total cholesterol, triglycerides, lipid corrected β-carotene, serum retinol, glucose, insulin, retinol binding protein-4, leptin, adiponectin, leptin-to-adiponectin ratio, high-sensitivity C-reactive protein, and interleukin-6 were measured before and after the 6-month intervention. Homeostasis model assessment-insulin resistance (HOMA-IR), acute insulin response to intravenous glucose, along with abdominal fat mass (dual-energy x-ray absorptiometry) were also determined.
Baseline β-carotene concentrations correlated inversely with HOMA-IR, leptin-to-adiponectin ratio, and abdominal fat mass (P ≤ .01). FVJC intake increased β-carotene concentrations (P ≤ .001) but did not influence retinol or retinol binding protein-4. Retinol insufficiency <1.047 μM was present in 18% of the entire cohort at baseline and in 37% at 6 months. HOMA-IR decreased after supplementation in the OW cohort, when adjusted for percent weight change (P = .014). The percent change in abdominal fat mass increased in the placebo group and decreased in the FVJC group (P = .029).
A 6-month supplementation with FVJC in the presence of nutritional counseling was associated with an increase in serum β-carotene concentrations and a reduction in adiposity in conjunction with an improvement in insulin resistance in OW boys.

Download full-text


Available from: Jose Canas
    • "The aim of the present study was to characterize the (poly) phenolic profile of three different plant-based food supplements designed to integrate and increase the daily intake of dietary phenolics. They are made from a total of 36 different vegetal matrices and have shown to exert wide biological effects in diverse health conditions [16] [17] [18] [19] [20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is continuously accruing evidence to suggest the health benefits of consuming fruits and vegetables. Food supplements may represent an effective and acceptable method to deliver a way of providing bioactive compounds to consumers. The aim of this work was to characterize the (poly)phenolic composition of three plant-based food supplements designed to integrate and increase the daily intake of dietary phenolics. The supplements are blends of berries, fruits, or vegetables made from a total of 36 different edible food plants. The best conditions for phenolic extraction were assessed and the total phenolic content of each supplement was estimated (it ranged from 50 to 176 mg/g powder). The analysis of the three supplements by uHPLC–MSn allowed to tentatively identify in all 119 (poly)phenolic compounds belonging to different classes, namely ellagitannins, gallotannins, dihydrochalcones, flavan-3-ols including proanthocyanidins, flavanones, flavones, flavonols, anthocyanins, hydroxybenzoic acids, hydroxycinnamic acids, phenylethanoids, and lignans. The contribution of these food supplements to the daily intake of (poly)phenolic compounds and, in turn, the potential contribution of such intake to health were discussed.
    No preview · Article · Jan 2015 · PharmaNutrition
    • "Animal intervention studies [7] [8] [9] [10] and human observational studies [11] [12] point to an inverse relationship between vitamin A status and body fat content. The concentration of BC in human adipocytes is reduced in obesity [13] and increases in serum levels of BC through diet associate with a reduction in adiposity in overweight children [14]. Studies in cell culture models and adult animals indicate that reduction of body fat by dietary vitamin A can be largely explained by its metabolism to biologically active retinoid derivatives, such as RA, which impact the differentiation and function of adipose tissues (reviewed in [1] [2]). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Scope: We studied β-carotene (BC) absorption and metabolism and compared BC and retinyl palmitate (RE) for their impact on white adipose tissue (WAT) development in suckling rats. Methods and results: Rat pups received daily orally from days 1-20 of life either the vehicle or vitamin A (approx. ×3 that ingested daily from maternal milk) in the form of BC or RE. Intact BC was found in serum and liver of BC-supplemented rats. Both BC and RE supplementation increased retinoic acid mediated transcriptional responses in intestine (on Isx and Bco1) and the liver (on Cyp26a1 and Cpt1a). In contrast, responses in WAT were dependent on the vitamin A source: WAT of BC-supplemented rats, like WAT of control rats, was enriched in larger adipocytes with increased adipogenic markers (peroxisome proliferator-activated receptor γ and downstream genes) and reduced markers of proliferative status (proliferating cell nuclear antigen) compared to WAT of RE-supplemented rats. Conclusion: BC is partly absorbed intact by suckling rats, which resembles the situation in humans and suggests that suckling rats may be an appropriate animal model to study BC uptake, metabolism and biological activity, particularly in infants. Vitamin A supplementation with BC or RE in early life differentially affects WAT and may thus entail different outcomes regarding adiposity programming.
    No preview · Article · Nov 2014 · Molecular Nutrition & Food Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: Circulating Retinol-Binding Protein 4 (RBP4) has recently been identified as a marker of insulin resistance. We tested this hypothesis in patients with coronary artery disease (CAD), patients with type 2 diabetes mellitus (T2DM), and in non-diabetic control subjects. We studied plasma RBP4 levels and RBP4-to-transthyrethin (TTR) ratio, estimating the excess circulating RBP4 in proportion to TTR, in 45 individuals divided into three groups (15 CAD, 15 T2DM, and 15 controls). Plasma RBP4 levels were significantly lower in patients with T2DM than in non-diabetic control subjects (P = 0.05). The RBP4/TTR ratio was not statistically different between the groups. There was no difference in plasma RBP4 levels and RBP4/TTR ratio between non-diabetic CAD patients and control subjects or those with and without metabolic syndrome. No significant associations were found between RBP4 and RBP4/TTR ratio, as dependent parameters, with markers of the metabolic syndrome and lipid metabolism. RBP4 does not seem to be a valuable marker for identification of the metabolic syndrome or insulin resistance in patients with T2DM or CAD.
    No preview · Article · Jun 2012 · International Journal of Diabetes in Developing Countries
Show more